These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
100 related items for PubMed ID: 7339239
1. Novel assay procedure for assessing ovarian function in women. Lindner HR, Kohen F, Eshhar Z, Kim JB, Barnard G, Collins WP. J Steroid Biochem; 1981 Dec; 15():131-6. PubMed ID: 7339239 [No Abstract] [Full Text] [Related]
2. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function. Magini A, Pinzani P, Bolelli GF, Bassi F, Salerno R, Messeri G, Pazzagli M. J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241 [Abstract] [Full Text] [Related]
3. Specificity studies of monoclonal and rabbit antibodies raised against steroid glucuronides. Samarajeewa P, Weerasekera DA, Coulson WF. Steroids; 1981 Dec; 38(6):667-78. PubMed ID: 6175056 [Abstract] [Full Text] [Related]
4. Determination of ovarian function using first morning urine steroid assays. Denari JH, Farinati Z, Casas PR, Oliva A. Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531 [Abstract] [Full Text] [Related]
5. Multiple immunoassay: the simultaneous measurement of two urinary steroid glucuronides as an index of ovarian function. Weerasekera DA, Kim JB, Barnard GJ, Collins WP. J Steroid Biochem; 1983 Apr; 18(4):465-70. PubMed ID: 6300555 [Abstract] [Full Text] [Related]
6. Use of monoclonal antibodies to pregnanediol-3 alpha-glucuronide for the development of a solid phase chemiluminescence immunoassay. Eshhar Z, Kim JB, Barnard G, Collins WP, Gilad S, Lindner HR, Kohen F. Steroids; 1981 Jul; 38(1):89-109. PubMed ID: 7292542 [Abstract] [Full Text] [Related]
7. Monitoring ovarian function by the simultaneous time-resolved fluorescence immunoassay of two urinary steroid metabolites. Barnard G, Kohen F. Clin Chem; 1998 Jul; 44(7):1520-8. PubMed ID: 9665432 [Abstract] [Full Text] [Related]
8. Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing. Blackwell LF, Vigil P, Gross B, d'Arcangues C, Cooke DG, Brown JB. Hum Reprod; 2012 Feb; 27(2):550-7. PubMed ID: 22131389 [Abstract] [Full Text] [Related]
9. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity. Wasalathanthri S, Tennekoon KH, Sufi S. Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010 [Abstract] [Full Text] [Related]
14. Improved performance of ELISAs for fertility assessment using common reagents and assay protocol as evidence from quality control studies. Desai MP, Donde UM, Khatkhatay MI. J Immunoassay Immunochem; 2002 Mar; 23(2):163-80. PubMed ID: 12033641 [Abstract] [Full Text] [Related]
16. Chemical and homogeneous enzyme immunoassay methods for the measurement of estrogens and pregnanediol and their glucuronides in urine. Brown JB, Blackwell LF, Cox RI, Holmes JM, Smith MA. Prog Clin Biol Res; 1988 Mar; 285():119-38. PubMed ID: 3068673 [No Abstract] [Full Text] [Related]
18. Use of a monoclonal antibody to estrone-3-glucuronide in an enzyme-linked immunosorbent assay (ELISA). Elder PA, Manley L, Lewis JG. J Steroid Biochem; 1990 Aug 14; 36(5):439-43. PubMed ID: 2170764 [Abstract] [Full Text] [Related]
19. Urinary hormone analysis as a diagnostic tool to evaluate the ovarian function of female gorillas (Gorilla gorilla). Czekala NM, Roser JF, Mortensen RB, Reichard T, Lasley BL. J Reprod Fertil; 1988 Jan 14; 82(1):255-61. PubMed ID: 3339583 [Abstract] [Full Text] [Related]
20. Simultaneous dosage of oestrone-3-glycuronide and pregnanediol-3-glycuronide in urines to monitor the fertile period in the woman. Cortesi S, Fortunato A, Marzot E, Soffiati G. Acta Eur Fertil; 1991 Jan 14; 22(1):27-31. PubMed ID: 1746204 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]